Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial-Reference-Cited by-同舟云学术

Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial

Published:2021-04-16 Issue:10 Volume:65 Page:2001178
ISSN:1613-4125
Container-title:Molecular Nutrition & Food Research
language:en
Short-container-title:Mol. Nutr. Food Res.

Author:

Amerikanou Charalampia¹,Kanoni Stavroula²,Kaliora Andriana C.¹,Barone Angela³,Bjelan Mladen⁴,D'Auria Giuseppe⁵⁶,Gioxari Aristea¹,Gosalbes María José⁶⁷,Mouchti Sofia³,Stathopoulou Maria G.⁸,Soriano Beatriz⁹,Stojanoski Stefan⁴¹⁰,Banerjee Rajarshi³,Halabalaki Maria¹¹,Mikropoulou Eleni V.¹¹,Kannt Aimo¹²¹³¹⁴,Lamont John¹⁵,Llorens Carlos⁹,Marascio Fernando¹⁶,Marascio Miriam¹⁶,Roig Francisco J.⁹¹⁷,Smyrnioudis Ilias¹⁸,Varlamis Iraklis¹⁹,Visvikis‐Siest Sophie⁸,Vukic Milan²⁰,Milic Natasa⁴,Medic‐Stojanoska Milica⁴²¹,Cesarini Lucia²²,Campolo Jonica²³,Gastaldelli Amalia²⁴^ORCID,Deloukas Panos²²⁵,Trivella Maria Giovanna²³²⁴,Francino M. Pilar⁶⁷,Dedoussis George V.¹^ORCID,

Affiliation:

1. Department of Nutrition and Dietetics, School of Health Science and Education Harokopio University Athens Greece

2. William Harvey Research Institute, Barts and The London School of Medicine and Dentistry Queen Mary University of London London EC1M 6BQ UK

3. Perspectum Ltd Oxford UK

4. Faculty of Medicine University of Novi Sad Novi Sad Serbia

5. Sequencing and Bioinformatics Service Fundació per al Foment de la Investigació Sanitària i Biomèdica de la Comunitat Valenciana (FISABIO‐Salut Pública) Avda. Catalunya 21 València 46020 Spain

6. CIBER en Epidemiología y Salud Pública Av. Monforte de Lemos 3–5 Madrid 28029 Spain

7. Joint Research Unit in Genomics and Health Fundació per al Foment de la Investigació Sanitària i Biomèdica de la Comunitat Valenciana (FISABIO) and Institut de Biologia Integrativa de Sistemes (Universitat de València / Consejo Superior de Investigaciones Científicas) Avda. Catalunya 21 València 46020 Spain

8. UMR INSERM U1122; IGE‐PCV University of Loraine Nancy France

9. Biotechvana, Parc Científic Universitat de València Paterna Valencia Spain

10. Centre for Imaging Diagnostics Oncology Insitute of Vojvodina Sremska Kamenica Serbia

11. Division of Pharmacognosy and Natural Products Chemistry Department of Pharmacy National and Kapodistrian University of Athens Athens Greece

12. Sanofi Research and Development Industriepark Hoechst Frankfurt 65926 Germany

13. Institute of Clinical Pharmacology Goethe University Frankfurt Frankfurt 60590 Germany

14. Fraunhofer Institute for Translational Medicine and Pharmacology ITMP Frankfurt 60596 Germany

15. Randox Laboratories Limited, Crumlin, Co. Antrim Northern Ireland UK

16. Marascio Fernando, Intervideo Catanzaro CZ 88100 Italy

17. Facultad de Ciencias de la Salud Universidad San Jorge Zaragoza 50830 Spain

18. Chios Mastic Gum Growers Association, Chios Greece

19. Department of Informatics and Telematics Harokopio University Athens Greece

20. Department of Food Technology, Faculty of Technology Zvornik University of East Sarajevo Zvornik 75400 Bosnia and Herzegovina

21. Clinic for Endocrinology, Diabetes and Metabolic Diseases Clinical Centre of Vojvodina Novi Sad Serbia

22. Division of Hepatology and Gastroenterology Niguarda Ca' Grande Hospital Milan Italy

23. Institute of Clinical Physiology CNR Milan Italy

24. Cardiometabolic Risk Unit Institute of Clinical Physiology, CNR Pisa Italy

25. Centre for Genomic Health, Life Sciences Queen Mary University of London London UK

Funder

H2020 Marie Skłodowska-Curie Actions

Publisher

Wiley

Subject

Food Science,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mnfr.202001178

Reference46 articles.

1. EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

2. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies

3. Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis

4. Noninvasive Diagnosis of NAFLD and NASH

5. Current status of imaging in nonalcoholic fatty liver disease

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytochemical investigation of Pistacia lentiscus L. var. Chia leaves: A byproduct with antimicrobial potential;Fitoterapia;2023-10

2. Plasma Amino Acids in NAFLD Patients with Obesity Are Associated with Steatosis and Fibrosis: Results from the MAST4HEALTH Study;Metabolites;2023-08-18

3. Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD;International Journal of Molecular Sciences;2023-08-13

4. Chios mastiha essential oil exhibits antihypertensive, hypolipidemic and anti-obesity effects in metabolically unhealthy adults - a randomized controlled trial;Pharmacological Research;2023-08

5. Exploring the Impact of Nutrition on Non-Alcoholic Fatty Liver Disease Management: Unveiling the Roles of Various Foods, Food Components, and Compounds;Nutrients;2023-06-22